Remove Decision Making Remove Mentoring Remove Pharmaceutical
article thumbnail

Exploding Myths About Schizophrenia: An Interview with Courtenay Harding

Mad in America

The recipient of many honors, she received the Alexander Gralnick Research Investigator Award from the American Psychological Foundation for “exceptional contributions to the study of schizophrenia and other serious mental illnesses and for mentoring a new generation of researchers.” ” This interview was conducted by email.

article thumbnail

Psychology, Personhood, and the Crisis of Neoliberalism: Jeff Sugarman on Theoretical and Critical Psychology

Mad in America

Just as I was beginning my doctoral work, he returned to Simon Fraser and became my mentor. You identify two main drivers behind this rise: first, the explosion of pharmaceutical advertising in the 1990s, and second, the growing expectation that we must constantly market and network ourselves as prerequisites for a successful life.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to manage conflict on your team when you’ve been avoiding it forever

Work Life

Research has shown that teams often benefit when someone is assigned to be a “deviant,” or to make waves and push the group to explore new ideas. I worked with one global pharmaceutical client that was struggling to adapt to rapid growth as the demand for a blockbuster drug skyrocketed.

article thumbnail

Introducing the SUCCESS 125

Success

And for the sixth time, we have done the research to find the 25 most influential leaders in this space: the coaches, speakers, authors, mentors and thought leaders to know in 2022. He is a teacher, a mentor, a coach, a convener, and a doer. Coach, mentor, creator. But this year, there’s more. Elena Cardone. Cindy Castillo.

article thumbnail

AI will eliminate many ‘blue-collar’ jobs—and 4 other AI predictions

Work Life

Rethinking the Workplace By the 2040s, almost all data will be digitized—which means AI will have access to it all for decision-making and optimization. Pharmaceutical companies will find their R&D costs cut significantly, simply because AI can help invent many drugs at much lower costs, including cures for rare diseases.